RenovoRx is thrilled to announce that Klaus W. Hambuechen, Laurence Marton, MD, and Una Ryan, PhD, have joined Marta Gaia Zanchi, PhD, CEO and Dr. Ramtin Agah, MD, CMO on the Company’s Board of Directors. Our three new members bring to the Board their vision, outstanding wealth of expertise and in-depth knowledge of the medical device, biotechnology and pharmaceutical industries, as well as their extensive global network of healthcare professionals and business leaders.
RenovoRx Announces New Board of Directors Members
- RenovoRx Announces Sixth U.S. Patent
- RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
- Parexel Biotech and RenovoRx Reach Key Milestone in Pancreatic Cancer Clinical Trial for Locally-Advanced Pancreatic Cancer
- RenovoRx Announces Issuance of Fifth U.S. Patent
- Contemporary Management of Pancreatic Cancer